High specificity of V3 serotyping among human immunodeficiency virus type-1 subtype C infected patients with varying disease status and viral phenotype

Journal of Medical Virology

Volumn 78, Issue 10, 2006, Pages 1262-1268

  Walker, Polly R ^a,b   Cilliers, Tonie ^b   Choge, Isaac A ^b   Taylor, Natasha ^b   Cohen, Sarah S ^b   Morris, Lynn ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

HIV 1 subtyping; V3 heterogeneity

Indexed keywords

ANTIBODY; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 120 ANTIBODY; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS PATIENT; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; COMPETITIVE PEPTIDE ENZYME IMMUNOASSAY; CONSENSUS SEQUENCE; CROSS REACTION; DISEASE COURSE; DISEASE SEVERITY; ENZYME IMMUNOASSAY; GENETIC HETEROGENEITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHENOTYPE; SEROTYPING; SOUTH AFRICA; SYNCYTIUM; VIRUS TRANSMISSION;

CELL LINE, TRANSFORMED; COHORT STUDIES; CROSS REACTIONS; DISEASE PROGRESSION; FEMALE; GIANT CELLS; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SEROTYPING; SOUTH AFRICA; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33748675274     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20690     Document Type: Article

References (28)

1. Barin F, Lahbabi Y, Buzelay L, Lejeune B, Baillou-Beaufils A, Denis F, Mathiot C, M'Boup S, Vithayasai V, Dietrich U, Goudeau A. 1996. Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: An approach for HIV type 1 serological subtyping. AIDS Res Hum Retroviruses 12:1279-1289.
2. Barin F, Plantier JC, Brand D, Brunet S, Moreau A, Liandier B, Thierry D, Cazein F, Lot F, Semaille C, Desenclos JC. 2006. Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic. J Med Virol 78:S13-S18.
3. Binley JM, Klasse PJ, Cao Y, Jones I, Markowitz M, Ho DD, Moore JP. 1997. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J Virol 71:2799-2809.
4. Bredell H, Hunt G, Casteling A, Cilliers T, Rademeyer C, Coetzer M, Miller S, Johnson D, Tiemessen CT, Martin DJ, Williamson C, Morris L. 2002. HIV-1 Subtype A, D, G, AG and unclassified sequences identified in South Africa. AIDS Res Hum Retroviruses 18:681-683.
5. Cheingsong-Popov R, Williamson C, Lister S, Morris L, van Harmelen J, Bredell H, Wood R, Sonnenberg P, van der Ryst E, Martin D, Weber J. 1998. Usefulness of HIV-1 V3 serotyping in studying the HIV-1 epidemic in South Africa. AIDS 12:949-950.
6. Choge I, Cilliers T, Walker P, Taylor N, Phoswa M, Meyers T, Viljoen J, Violari A, Gray G, Moore P, Papathanosopoulos M, Morris L. 2006. Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C infected children with slow and rapid disease progression. AIDS Res Hum Retroviruses 22:458-465.
7. Cilliers T, Nhlapo J, Coetzer M, Orlovic D, Ketas T, Olson WC, Moore JP, Trkola A, Morris L. 2003. The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. J Virol 77:4449-4456.
8. Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI. 1994. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol 68:6672-6683.
9. Engelbrecht S, Smith TL, Kasper P, Faatz E, Zeier M, Moodley D, Clay CG, van Rensburg EJ. 1999. HIV type 1 V3 domain serotyping and genotyping in Gauteng, Mpumalanga, KwaZulu-Natal, and Western Cape Provinces of South Africa. AIDS Res Hum Retroviruses 15:325-328.
10. Gaschen B, Korber BT, Foley BF. 1999. Part VII Global variation in the HIV-1 V3 region. The Human Retroviruses and AIDS 1999 Compendium.
11. Grobler J, Gray CM, Rademeyer C, Seoighe C, Ramjee G, Karim SA, Morris L, Williamson C. 2004. Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. J Infect Dis 190:1355-1359.
12. Hoelscher M, Hanker S, Barin F, Cheingsong-Popov R, Dietrich U, Jordan-Harder B, Olaleye D, Nagele E, Markuzzi A, Mwakagile D, Minja F, Weber J, Gurtler L, Von Sonnenburg F. 1998. HTV type 1 V3 serotyping of Tanzanian samples: Probable reasons for mismatching with genetic subtyping. AIDS Res Hum Retroviruses 14:139-149.
13. Kuiken C, Foley B, Freed E, Hahn B, Korber B, Marx PA, McCutchan F, Mellors JW, Wolinksy S. 2004. HIV Sequence Compendium. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, LA-UR 03-3564.
14. Lot F, Semaille C, Cazein F, Barin F, Pinget R, Pillonel J, Desenclos JC. 2004. Preliminary results from the new HIV surveillance system in France. Euro Surveill 9:34-37.
15. Moore JP, Cao Y, Conley AJ, Wyatt R, Robinson J, Gorny MK, Zolla-Pazner S, Ho DD, Koup RA. 1994. Studies with monoclonal antibodies to the V3 region of HIV-1 gp120 reveal limitations to the utility of solid-phase peptide binding assays. J Acquir Immune Defic Syndr 7:332-339.
16. Morris L, Cilliers T, Bredell H, Phoswa M, Martin DJ. 2001. CCR5 is the major coreceptor used by HIV-1 subtype C isolates from patients with active tuberculosis. AIDS Res Hum Retroviruses 17:697-701.
17. Murphy G, Belda FJ, Pau CP, Clewley JP, Parry JV. 1999. Discrimination of subtype B and non-subtype B strains of human immunodeficiency virus type 1 by serotyping: Correlation with genotyping. J Clin Microbiol 37:1356-1360.
18. Nelson JA, Baribaud F, Edwards T, Swanstrom R. 2000. Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection. J Virol 74:8494-8501.
19. Nkengasong JN, Willems B, Janssens W, Cheingsong-Popov R, Heyndrickx L, Barin F, Ondoa P, Fransen K, Goudsmit J, van der Groen G. 1998. Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtypjng and genetic sequencing. Aids 12:1405-1412.
20. Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J. 2002. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 29:184-190.
21. Peeters M, Vincent R, Perret JL, Lasky M, Patrel D, Liegeois F, Courgnaud V, Seng R, Matton T, Molinier S, Delaporte E. 1999. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: Syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J Acquir Immune Defic Syndr Hum Retrovirol 20:115-121.
22. Ping LH, Nelson JA, Hoffman IF, Schock J, Lamers SL, Goodman M, Vernazza P, Kazembe P, Maida M, Zimba D, Goodenow MM, Eron JJ, Jr., Fiscus SA, Cohen MS, Swanstrom R. 1999. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: Underrepresentation of X4 variants. J Virol 73:6271-6281.
23. Plantier JC, Damond F, Lasky M, Sankale JL, Apetrei C, Peeters M, Buzelay L, M'Boup S, Kanki P, Delaporte E, Simon F, Barin F. 1999. V3 serotyping of HIV-1 infection: Correlation with genotyping and limitations. J Acquir Immune Defic Syndr Hum Retrovirol 20:432-441.
24. Plantier JC, Vergne L, Damond F, M'Boup S, MPoudi-NGole E, Buzelay L, Farfara I, Brand D, Peeters M, Brun-Vezinet F, Delaporte E, Barin F. 2002. Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG. J Clin Microbiol 40:1010-1022.
25. Ramjee G, Karim SS, Sturm AW. 1998. Sexually transmitted infections among sex workers in KwaZulu-Natal, South Africa. Sex Transm Dis 25:346-349.
26. Subbramanian RA, Xu J, Toma E, Morisset R, Cohen EA, Menezes J, Ahmad A. 2002. Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients. J Clin Microbiol 40:2141-2146.
27. UNAIDS. 2004. Joint United Nations Programme on HIV/AIDS (UNAIDS) World Health Organization (WHO). AIDS Epidemic Update.
28. Williamson C, Morris L, Maughan MF, Ping LH, Dryga SA, Thomas R, Reap EA, Cilliers T, van Harmelen J, Pascual A, Ramjee G, Gray G, Johnston R, Karim SA, Swanstrom R. 2003. Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. AIDS Res Hum Retroviruses 19:133-144.